ATI
MRK icon

Act Two Investors’s Merck MRK Stock Holding History

Act Two Investors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-344,706
Closed -$25.4M – 35
2021
Q1 		$25.4M Buy
344,706
+17,266
+5% +$1.27M 5.59% 10
2020
Q4 		$25.6M Buy
327,440
+48,773
+18% +$3.73M 6.45% 9
2020
Q3 		$22.1M Buy
+278,667
New +$21.8M 7.13% 7

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Act Two Investors's MRK Position: Q2 2021 in Review

Act Two Investors sold out of Merck (MRK) in Q2 2021, closing a stake of 344,706 shares — an estimated $25.4M sold.

Act Two Investors first reported a position in MRK in Q3 2020 and held it in 3 quarters. The position peaked at $25.6M in Q4 2020. 2,673 funds tracked by Wall St. Rank hold MRK as of Q2 2021.

  • Act Two Investors reported no remaining Merck position as of Q2 2021 after selling out during the quarter.
  • Act Two Investors sold 344,706 Merck shares in Q2 2021, an estimated $25.4M.
  • Act Two Investors first reported a position in Merck in Q3 2020 and held it in 3 quarters.
  • Act Two Investors's Merck position peaked at $25.6M in Q4 2020.
  • 2,673 funds tracked by Wall St. Rank held Merck as of Q2 2021.

Based on Act Two Investors's 13F filing for Q2 2021, filed 12 Aug 2021.